IL134259A0 - Use of physiologically acceptable vanadium compounds, salts and complexes - Google Patents
Use of physiologically acceptable vanadium compounds, salts and complexesInfo
- Publication number
- IL134259A0 IL134259A0 IL13425998A IL13425998A IL134259A0 IL 134259 A0 IL134259 A0 IL 134259A0 IL 13425998 A IL13425998 A IL 13425998A IL 13425998 A IL13425998 A IL 13425998A IL 134259 A0 IL134259 A0 IL 134259A0
- Authority
- IL
- Israel
- Prior art keywords
- physiologically acceptable
- complexes
- salts
- vanadium compounds
- acceptable vanadium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Dermatology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1006681A NL1006681C2 (nl) | 1997-07-29 | 1997-07-29 | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
| PCT/NL1998/000431 WO1999006056A1 (fr) | 1997-07-29 | 1998-07-29 | Utilisation de composes, de sels et de complexes de vanadium acceptables sur le plan physiologique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL134259A0 true IL134259A0 (en) | 2001-04-30 |
Family
ID=19765422
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL13425998A IL134259A0 (en) | 1997-07-29 | 1998-07-29 | Use of physiologically acceptable vanadium compounds, salts and complexes |
| IL134259A IL134259A (en) | 1997-07-29 | 2000-01-27 | Use of physiologically acceptable vanadium compounds, salts and complexes in the preparation of pharmaceutical compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL134259A IL134259A (en) | 1997-07-29 | 2000-01-27 | Use of physiologically acceptable vanadium compounds, salts and complexes in the preparation of pharmaceutical compositions |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6579540B1 (fr) |
| EP (1) | EP1001792B1 (fr) |
| JP (1) | JP2001511454A (fr) |
| CN (1) | CN1104244C (fr) |
| AT (1) | ATE253373T1 (fr) |
| AU (1) | AU738701B2 (fr) |
| BR (1) | BR9811298A (fr) |
| CA (1) | CA2298645C (fr) |
| CZ (1) | CZ299716B6 (fr) |
| DE (1) | DE69819514T2 (fr) |
| DK (1) | DK1001792T3 (fr) |
| EA (1) | EA002574B1 (fr) |
| ES (1) | ES2207851T3 (fr) |
| ID (1) | ID24870A (fr) |
| IL (2) | IL134259A0 (fr) |
| NL (1) | NL1006681C2 (fr) |
| NO (1) | NO20000446L (fr) |
| NZ (1) | NZ502613A (fr) |
| PL (1) | PL338415A1 (fr) |
| PT (1) | PT1001792E (fr) |
| TR (1) | TR200000349T2 (fr) |
| WO (1) | WO1999006056A1 (fr) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL1006681C2 (nl) * | 1997-07-29 | 1999-02-08 | Gho St Holding Bv | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
| US8192994B2 (en) * | 1998-02-10 | 2012-06-05 | Angros Lee H | Method of applying a biological specimen to an analytic plate |
| WO2001045716A1 (fr) * | 1999-12-20 | 2001-06-28 | Gho'st Holding B.V. | Composition pharmaceutique comprenant un compose, un sel ou un complexe de vanadium, acceptable au plan physiologique, et un inhibiteur d'echange na?+/h+¿ |
| WO2003041703A2 (fr) * | 2001-11-16 | 2003-05-22 | Gho Holding B.V. | Methode de traitement des brulures |
| ES2485384T3 (es) | 2007-01-31 | 2014-08-13 | Basf Plant Science Gmbh | Plantas que tienen rasgos potenciados relacionados con el rendimiento y/o mayor resistencia al estrés abiótico y un procedimiento para fabricar las mismas |
| EP2228386B1 (fr) | 2007-05-03 | 2015-03-18 | BASF Plant Science GmbH | Installations dotées de caractéristiques de rendement améliorées et procédé de fabrication de celles-ci |
| AU2008280152B2 (en) | 2007-07-20 | 2013-11-21 | Basf Plant Science Gmbh | Plants having increased yield-related traits and a method for making the same |
| AR067748A1 (es) | 2007-07-31 | 2009-10-21 | Basf Plant Science Gmbh | Plantas que tienen rasgos mejorados relacionados con el rendimiento y un metodo para obtenerlas |
| CN102936605A (zh) | 2007-10-29 | 2013-02-20 | 巴斯夫植物科学有限公司 | 具有增强的产量相关性状的植物和用于制备该植物的方法 |
| AU2009243552A1 (en) | 2008-05-05 | 2009-11-12 | Basf Plant Science Gmbh | Plants having enhanced yield-related traits and a method for making the same |
| US20100078320A1 (en) * | 2008-09-26 | 2010-04-01 | Applied Materials, Inc. | Microwave plasma containment shield shaping |
| BR112012017535A2 (pt) | 2010-01-15 | 2019-09-24 | Of Medicine And Dentistry Of New Jersey University | uso de compostos de vanádio para cicatrização de osso |
| EP2648718B1 (fr) | 2010-12-10 | 2019-05-08 | Rutgers, the State University of New Jersey | Dispositifs implantables revêtus de composites d'agent mimétique de l'insuline, et procédés associés |
| US20140322292A1 (en) | 2010-12-10 | 2014-10-30 | Rutgers, The State University Of New Jersey | Insulin-mimetics as therapeutic adjuncts for bone regeneration |
| CA2829259C (fr) * | 2011-03-07 | 2020-02-25 | Cfm Pharma Holding Bv | Utilisation de composes de pour maintenir la normoglycemie chez un mammifere |
| US9931348B2 (en) * | 2011-07-06 | 2018-04-03 | Rutgers, The State University Of New Jersey | Vanadium compounds as therapeutic adjuncts for cartilage injury and repair |
| PL231079B1 (pl) | 2012-11-07 | 2019-01-31 | Univ Jagiellonski | Kompleksy wanadu z hydrazydohydrazonami, preparaty farmaceutyczne oraz zastosowanie kompleksów wanadu z hydrazydohydrazonami |
| NL2019605B1 (en) * | 2017-09-22 | 2019-03-28 | Cfm Pharma Holding B V | Vanadyl and vanadate for use in reducing stress-induced metabolic derangement |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU5448490A (en) * | 1989-04-24 | 1990-11-16 | Board Of Regents, The University Of Texas System | Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue |
| US5565491A (en) * | 1994-01-31 | 1996-10-15 | Bristol-Myers Squibb Company | Use of phosphotyrosine phospatase inhibitors for controlling cellular proliferation |
| FR2729957B1 (fr) * | 1995-01-31 | 1997-12-05 | Maurel Sante | Complexes organometalliques a base de sitosterols et d'acylglycerols et compositions pharmaceutiques et produits dietetiques en contenant. |
| NL1006681C2 (nl) * | 1997-07-29 | 1999-02-08 | Gho St Holding Bv | Toepassing van fysiologisch acceptabele vanadiumverbindingen, -zouten en -complexen. |
-
1997
- 1997-07-29 NL NL1006681A patent/NL1006681C2/nl not_active IP Right Cessation
-
1998
- 1998-07-29 WO PCT/NL1998/000431 patent/WO1999006056A1/fr active IP Right Grant
- 1998-07-29 DK DK98937862T patent/DK1001792T3/da active
- 1998-07-29 AU AU86505/98A patent/AU738701B2/en not_active Ceased
- 1998-07-29 CA CA002298645A patent/CA2298645C/fr not_active Expired - Fee Related
- 1998-07-29 CN CN98809293A patent/CN1104244C/zh not_active Expired - Fee Related
- 1998-07-29 PL PL98338415A patent/PL338415A1/xx unknown
- 1998-07-29 BR BR9811298-8A patent/BR9811298A/pt not_active Application Discontinuation
- 1998-07-29 ES ES98937862T patent/ES2207851T3/es not_active Expired - Lifetime
- 1998-07-29 AT AT98937862T patent/ATE253373T1/de not_active IP Right Cessation
- 1998-07-29 IL IL13425998A patent/IL134259A0/xx unknown
- 1998-07-29 EA EA200000176A patent/EA002574B1/ru not_active IP Right Cessation
- 1998-07-29 TR TR2000/00349T patent/TR200000349T2/xx unknown
- 1998-07-29 DE DE69819514T patent/DE69819514T2/de not_active Expired - Lifetime
- 1998-07-29 ID IDW20000183A patent/ID24870A/id unknown
- 1998-07-29 PT PT98937862T patent/PT1001792E/pt unknown
- 1998-07-29 CZ CZ20000326A patent/CZ299716B6/cs not_active IP Right Cessation
- 1998-07-29 NZ NZ502613A patent/NZ502613A/en not_active IP Right Cessation
- 1998-07-29 US US09/463,697 patent/US6579540B1/en not_active Expired - Lifetime
- 1998-07-29 EP EP98937862A patent/EP1001792B1/fr not_active Expired - Lifetime
- 1998-07-29 JP JP2000504869A patent/JP2001511454A/ja active Pending
-
2000
- 2000-01-27 IL IL134259A patent/IL134259A/en not_active IP Right Cessation
- 2000-01-28 NO NO20000446A patent/NO20000446L/no not_active Application Discontinuation
-
2003
- 2003-04-21 US US10/419,914 patent/US20030211170A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1270525A (zh) | 2000-10-18 |
| EA200000176A1 (ru) | 2000-10-30 |
| TR200000349T2 (tr) | 2000-09-21 |
| AU8650598A (en) | 1999-02-22 |
| NO20000446D0 (no) | 2000-01-28 |
| US20030211170A1 (en) | 2003-11-13 |
| DE69819514T2 (de) | 2004-09-23 |
| EP1001792B1 (fr) | 2003-11-05 |
| DK1001792T3 (da) | 2004-01-19 |
| NL1006681C2 (nl) | 1999-02-08 |
| ATE253373T1 (de) | 2003-11-15 |
| WO1999006056A1 (fr) | 1999-02-11 |
| BR9811298A (pt) | 2000-08-29 |
| EP1001792A1 (fr) | 2000-05-24 |
| CA2298645A1 (fr) | 1999-02-11 |
| AU738701B2 (en) | 2001-09-27 |
| US6579540B1 (en) | 2003-06-17 |
| CZ299716B6 (cs) | 2008-10-29 |
| DE69819514D1 (de) | 2003-12-11 |
| NO20000446L (no) | 2000-03-24 |
| NZ502613A (en) | 2001-08-31 |
| CN1104244C (zh) | 2003-04-02 |
| ID24870A (id) | 2000-08-31 |
| IL134259A (en) | 2010-02-17 |
| PL338415A1 (en) | 2000-11-06 |
| CA2298645C (fr) | 2004-05-18 |
| PT1001792E (pt) | 2004-03-31 |
| ES2207851T3 (es) | 2004-06-01 |
| EA002574B1 (ru) | 2002-06-27 |
| CZ2000326A3 (cs) | 2000-07-12 |
| JP2001511454A (ja) | 2001-08-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL134259A0 (en) | Use of physiologically acceptable vanadium compounds, salts and complexes | |
| UA56989C2 (uk) | ФІЗІОЛОГІЧНО АКТИВНИЙ ПЕГ-КОН'ЮГАТ <font face="Symbol">a</font>-ІНТЕРФЕРОНУ, СПОСІБ ЙОГО ОДЕРЖАННЯ, ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ НА ЙОГО ОСНОВІ ТА СПОСІБ ЛІКУВАННЯ АБО ПРОФІЛАКТИКИ ІМУНОМОДУЛЯТОРНИХ ЗАХВОРЮВАНЬ | |
| EP0509317A3 (en) | Use of droloxifene in the treatment of bone diseases | |
| WO1995031985A3 (fr) | Compositions pharmaceutiques contenant un antagoniste des opiaces et des sels de calcium, et leur utilisation dans le traitement de pathologies a mediation endorphinique | |
| PL299814A1 (en) | Pharmaceutical preparation inhibiting depletion of human bone tissue | |
| TR200000129T2 (tr) | Yepyeni spiroazabisiklik heterosiklik bileşikler. | |
| WO2003009838A1 (fr) | Utilisation de composes de stilbene dans la preparation de medicaments pour le traitement ou la prevention du diabete et des maladies associees au retrovirus | |
| ES2160643T3 (es) | Composiciones que contienen g-csf y proteina de union al tnf. | |
| CA2179015A1 (fr) | Utilisation de bis(amidinobenzimidazoles) dans la fabrication de medicaments destines a inhiber l'integrase retrovirale | |
| CA2289017A1 (fr) | Utilisation d'oxydes d'azote ou de promedicament a base de ces oxydes pour la prevention et le traitement therapeutique du cancer | |
| CA2385755A1 (fr) | Prevention du cancer colorectal | |
| IL120495A0 (en) | Use of alpha1-adrenoreceptor antagonists in the prevention and treatment of cancer | |
| CA2394471A1 (fr) | Agent antipruritique a usage externe | |
| BG106151A (en) | Pharmaceutical complex | |
| ES2065855A1 (es) | Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos. | |
| BR0115911A (pt) | Uso de pirazolo[4,3-d]pirimidinas | |
| WO2001045717A3 (fr) | COMPOSITION PHARMACEUTIQUE COMPRENANT UN COMPOSE DE VANADIUM PHYSIOLOGIQUEMENT ACCEPTABLE, UN SEL OU UN COMPLEXE DE CE COMPOSE ET AU MOINS UN CONSTITUANT CHOISI PARMI DES INHIBITEURS D'ECHANGEUR DE Na+/H+, DES INHIBITEURS DE CYCLO-OXYGENASE ET DES INHIBITEURS DE CASPASE | |
| TR200200111T2 (tr) | Neoplazmalar için terapötik ve profilaktik maddeler | |
| GR20010100390A (el) | Χρηση του diclofenac h αποδεκτων αλατων αυτου για την αντιμετωπιση των εγκαυματων. | |
| UA41326C2 (uk) | Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань | |
| WO1998042312A3 (fr) | Medicament exerçant un effet sclerosant | |
| PL367628A1 (en) | Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia | |
| ZA200100289B (en) | Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis. | |
| TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
| UA12937A (uk) | Засіб для локальhого лікуваhhя гhійhо-запальhих раh та опіків, іhфіковаhих стафілококом |